• SENSEX 74,525.19
    -256.57 (--0.34%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Solar Industries
    19,450.15 11,641.10(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • TCS
    2,322.50 3,336.70(%)
  • Reliance Industries
    1,249.00 1,250.55(%)
  • Pine Labs
    191.50 134.75(%)
  • Netweb Technol.
    4,675.00 2,820.80(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,882.00 1,575.00(%)
  • SBI
    979.00 816.25(%)
  • Bharat Electron
    387.65 380.35(%)
  • Coforge
    1,780.00 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • IFCI
    77.80 46.20(%)
  • Molbio Diagnosti
    1,274.05 925.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pfizer Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 434.0
  • ISIN : INE182A01018
4,060.20 -35 (-0.86%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    4,054.00

  • Today’s High

    4,123.80

  • Open

    4,103.10

  • Perv Close

    4,095.40

  • 52W Low

    4,054.00

  • 52W High

    5,578.50

Key Indicators

  • P/E(TTM)

    24.16

  • Mar.Cap (₹Cr.)

    18,574.49

  • Div & Yield %

    1.85

  • Book Value(₹)

    918.71

  • Debt-Equity Ratio

    -0.86

  • AGM Date

    11-Sep-2026

  • EPS

    168.11

  • P/E Ratio

    24.16

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    18,574.49

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    45.75

  • BV (₹)

    918.70

  • Sales( ₹ in Cr.)

    2,519.65

  • NP (in Cr.)

    758.68

  • NP Var(%)

    37.0

  • Div%

    750.0

  • CPS (₹)

    178.50

  • EPS (₹)

    165.80

  • Traded Value (₹ in Lakhs)

    18,582.96

  • 52 Week High

    5,578.50

  • 52 Week Low

    4,054.00

  • Price BSE

    4062.0

  • Price NSE

    4,060.00

  • Market Capital( in Cr.)

    18,582.96

  • P/C Ratio

    22.80

  • P/E Ratio

    24.50

  • Price Vs.BV

    165.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,519.65 2,281.35 2,193.17 2,424.76 2,610.99 2,238.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,519.65 2,281.35 2,193.17 2,424.76 2,610.99 2,238.55
Other Income 187.95 345.06 188.46 134.05 62.65 81.12
Stock Adjustments 33.59 -25.36 11.82 -56.48 72.90 -14.35
Total Income 2,741.19 2,601.05 2,393.45 2,502.33 2,746.54 2,305.32
EXPENDITURE :            
Raw Materials 917.90 785.09 804.39 817.19 1,020.93 783.39
Power and Fuel Cost 3.20 3.48 3.98 6.51 5.67 5.79
Employee Cost 367.97 371.33 347.80 331.68 403.67 361.06
Other Manufacturing Expenses 58.01 50.54 51.17 51.63 59.81 60.26
Selling and Administration Expenses 259.96 260.05 317.96 298.03 310.77 268.67
Miscellaneous Expenses 91.18 45.18 44.37 54.29 47.10 32.63
Employee Benefit Expenses 367.97 371.33 347.80 331.68 403.67 361.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,698.22 1,515.67 1,569.67 1,559.33 1,847.95 1,511.80
Operating Profit 1,042.97 1,085.38 823.78 943.00 898.59 793.52
Interest 9.57 8.50 15.43 13.48 10.70 15.39
Gross Profit 1,033.40 1,076.88 808.35 929.52 887.89 778.13
Depreciation 57.73 60.79 62.28 105.51 115.00 109.41
Profit Before Tax 975.67 1,016.09 746.07 824.01 772.89 668.72
Current Tax 257.52 264.10 158.63 251.99 196.26 183.63
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.28 -15.61 36.11 -51.91 -35.93 -12.52
Reported Net Profit 722.43 767.60 551.33 623.93 612.56 497.61
Extraordinary Items -36.25 215.80 3.62 22.95 1.13 0.06
Adjusted Net Profit 758.68 551.80 547.71 600.98 611.43 497.55
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2,435.86 1,828.39 1,460.05 1,133.47 681.03 1,693.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 754.84 160.13 182.99 297.35 160.12 1,509.66
P & L Balance carried down 2,403.45 2,435.86 1,828.39 1,460.05 1,133.47 681.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 750.00 1,650.00 350.00 400.00 350.00 350.00
Dividend Per Share(Rs) 75.00 165.00 35.00 40.00 35.00 35.00
Earnings Per Share-Unit Curr 157.91 167.78 120.51 136.38 133.89 108.77
Earnings Per Share(Adj)-Unit Curr 157.91 167.78 120.51 136.38 133.89 108.77
Book Value 918.67 921.84 785.91 701.05 626.10 523.07
Book Value(Adj)-Unit Curr 918.67 921.84 785.91 701.05 626.10 523.07

Shareholding Pattern

  • Promoter Group

    63.92%

  • Public Share Holding

    36.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 29,243,042 63.92 29,243,042 7
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 29,243,042 63.92 29,243,042 7
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 188 0.00 125 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 7,071 0.02 6,072 19
Foreign Bank 186 0.00 0 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 754,806 1.65 754,795 82
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,324,459 5.08 2,324,459 9
Mutual Funds / UTI 5,798,893 12.68 5,798,393 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,967 0.03 11,967 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,897,570 19.45 8,895,811 153
2] Non Institution
Bodies Corporate 1,273,216 2.78 1,268,661 611
Clearing Members 295 0.00 293 7
Directors of their Relatives 10 0.00 10 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 249,081 0.54 248,336 3,072
Foreign Non Institution Other 310 0.00 0 2
Hindu Undivided Families 145,275 0.32 145,275 2,096
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 211,636 0.46 211,636 11
Individuals holding nominal share capital up to Rs. 1 lakh 5,297,361 11.58 5,047,678 96,507
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,654 0.00 1,619 9
Others 428,282 0.94 428,282 2
Sub Total 7,607,120 16.63 7,351,790 102,318
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 45,747,732 100.00 45,490,643 102,478

Company Background

Pfizer LtdPharmaceuticals - Multinational

  • Pfizer Ltd
  • BSE Code : 434.0
  • ISIN : INE182A01018

  • Incorporation Year

    1950

  • Registered Office

    The Capital 1802/1901 Plot-C70
    G Bl Bandra Kurla Cpx Bandra-E, Mumbai,
    Maharashtra-400051

  • Telephone

    91-22-66932000

  • FAX

    91-22-26540274

  • Chairman

    Pradip Shah

  • Managing Director

    Meenakshi Nevatia

  • Company Secretary

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Pfizer Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pfizer 4,062.05 2,707.60 2,519.65 25.28 22.62
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77